2016
DOI: 10.1016/j.neuint.2016.03.003
|View full text |Cite|
|
Sign up to set email alerts
|

In vitro, molecular modeling and behavioral studies of 3-{[4-(5-methoxy-1H-indol-3-yl)-1,2,3,6-tetrahydropyridin-1-yl]methyl}-1,2-dihydroquinolin-2-one (D2AAK1) as a potential antipsychotic

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
53
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
9

Relationship

6
3

Authors

Journals

citations
Cited by 36 publications
(61 citation statements)
references
References 66 publications
7
53
1
Order By: Relevance
“…Notably, a number of following docking studies reported in literature described a unique receptor cavity involved in the 5-HT 1A full agonists, partial agonists and antagonists binding [58][59][60], giving a further validation to our previous computational findings. Indeed, H-bond interactions between agonists and D116 and N386 were reported in literature, falling in a crevice delimited by F112, I113, D116, K191, while partial agonists as well as antagonists were Hbonded at least with D116.…”
Section: -Ht 1a R Docking-studiessupporting
confidence: 85%
“…Notably, a number of following docking studies reported in literature described a unique receptor cavity involved in the 5-HT 1A full agonists, partial agonists and antagonists binding [58][59][60], giving a further validation to our previous computational findings. Indeed, H-bond interactions between agonists and D116 and N386 were reported in literature, falling in a crevice delimited by F112, I113, D116, K191, while partial agonists as well as antagonists were Hbonded at least with D116.…”
Section: -Ht 1a R Docking-studiessupporting
confidence: 85%
“…Chinese hamster ovary K1 (CHO-K1) cell lines stably expressing human D 2S , 5-HT 2A or H 1 receptors and human embryonic kidney 293 (HEK293) cell lines stably expressing human 5-HT 1A or 5-HT 7(a) receptors were in-house available [9][10][11], whereas CHO-K1 cell lines stably expressing human D 1 or D 3 receptors (Perkin Elmer, Waltham, MA, USA) and Chem-1 cell line stably expressing human M 1 receptor (Millipore, Merck KGaA, Darmstadt, Germany) were commercially available. Experimental conditions for binding assays at D 1 , D 2 , D 3 , 5-HT 1A and 5-HT 2A receptors have been previously reported [12]. 0.7 nM [ 3 H]-SCH23390, 2 nM [ 3 H]-SB269970 (5-HT 7 ), 2 nM [ 3 H]-Pyrilamine (H 1 ) and 2 nM [ 3 H]-Pirenzepine (M 1 ) were employed as radioligands.…”
Section: Receptor Binding Assaysmentioning
confidence: 99%
“…The efficacy of D2AAK4 as agonist or antagonist of D 2 receptors was evaluated in functional assays of cAMP signaling in the CHO-K1 cell line stably expressing the human D 2S receptor employed in radioligand binding assays, following a protocol already described [9,12]. Compound was initially assessed at 10 µM concentration either as agonist or as antagonist of 10 µM dopamine response.…”
Section: Functional Assay At D 2 Receptorsmentioning
confidence: 99%
“…2.9.1. Compound Preparation Compounds 1 and 2 were modeled using LigPrep module [23] of Schrödinger suite of software, v. 2019-4 as previously reported [24][25][26][27][28]. To identify the protonation state, Epik module [29] of Schrödinger suite of software, v. 2019-4 was applied.…”
Section: Molecular Modelingmentioning
confidence: 99%